DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Suvizumab
Suvizumab
WO 2015/063180 Al 7 May 2015 (07.05.2015) P O P C T
Predictive QSAR Tools to Aid in Early Process Development of Monoclonal Antibodies
Phage Display-Based Strategies for Cloning and Optimization of Monoclonal Antibodies Directed Against Human Pathogens
The Two Tontti Tudiul Lui Hi Ha Unit
INN Working Document 05.179 Update 2011
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Wo 2016/061562 A2 ©
(INN) for Biological and Biotechnological Substances
WO 2018/013551 Al 18 January 2018 (18.01.2018) W !P O PCT
WO 2017/011544 Al 19 January 2017 (19.01.2017) P O PCT
6.6.2018 a Abacavir Abacavirum Abakaviiri Abagovomab
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
(12) Patent Application Publication (10) Pub. No.: US 2017/0210797 A1 Kretz-Rommel Et Al
(12) United States Patent (10) Patent No.: US 9.295,731 B2 Nguyen (45) Date of Patent: Mar
Valstybinės Vaistų Kontrolės Tarnybos Prie Lietuvos Respublikos Sveikatos Apsaugos Ministerijos Viršininko Įsakymas
WO 2016/128558 Al 18 August 2016 (18.08.2016) P O P C T
Hep28280 Am.Pdf
Top View
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Antiviral Therapy in Chronic Hepatitis B Viral Infection During Pregnancy
QSAR Model Development for Early Stage Screening of Monoclonal Antibody Therapeutics to Facilitate Rapid Developability
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(INN) for Biological and Biotechnological Substances
WO 2018/231759 Al 20 December 2018 (20.12.2018) W !P O PCT
WO 2015/036956 Al 19 March 2015 (19.03.2015) P O P C T
WO 2013/120629 Al 22 August 2013 (22.08.2013) P O P C T
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Supplemental Table 1: Inclusion and Exclusion Criteria